# Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors

> **NCT00611494** · PHASE4 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 400 (estimated)

## Conditions studied

- Organ Transplantation

## Interventions

- **DRUG:** MMF
- **DRUG:** EC-MPS

## Key facts

- **NCT ID:** NCT00611494
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2009-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00611494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00611494, "Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00611494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
